128 related articles for article (PubMed ID: 26300990)
1. Triage of high-risk human papillomavirus-positive women by methylated POU4F3.
Pun PB; Liao YP; Su PH; Wang HC; Chen YC; Hsu YW; Huang RL; Chang CC; Lai HC
Clin Epigenetics; 2015; 7(1):85. PubMed ID: 26300990
[TBL] [Abstract][Full Text] [Related]
2. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA
Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534
[TBL] [Abstract][Full Text] [Related]
3. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Meijer CJLM; Melchers WJG; Bekkers RL; Molijn AC; Quint WG; van Kemenade FJ; Berkhof J; Heideman DAM
Int J Cancer; 2022 Feb; 150(3):440-449. PubMed ID: 34558659
[TBL] [Abstract][Full Text] [Related]
4. Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.
Kocsis A; Takács T; Jeney C; Schaff Z; Koiss R; Járay B; Sobel G; Pap K; Székely I; Ferenci T; Lai HC; Nyíri M; Benczik M
Int J Cancer; 2017 Mar; 140(5):1119-1133. PubMed ID: 27874187
[TBL] [Abstract][Full Text] [Related]
5. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women.
Hansel A; Steinbach D; Greinke C; Schmitz M; Eiselt J; Scheungraber C; Gajda M; Hoyer H; Runnebaum IB; Dürst M
PLoS One; 2014; 9(3):e91905. PubMed ID: 24647315
[TBL] [Abstract][Full Text] [Related]
6. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
7. Utility of gene methylation analysis, cytological examination, and HPV-16/18 genotyping in triage of high-risk human papilloma virus-positive women.
Tian Y; Yuan Wu NY; Liou YL; Yeh CT; Cao L; Kang YN; Wang HJ; Li Y; Chu TY; Li W; Liu X; Zhang Y; Zhou H; Zhang Y
Oncotarget; 2017 Sep; 8(37):62274-62285. PubMed ID: 28977944
[TBL] [Abstract][Full Text] [Related]
8. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
Overmeer RM; Louwers JA; Meijer CJ; van Kemenade FJ; Hesselink AT; Daalmeijer NF; Wilting SM; Heideman DA; Verheijen RH; Zaal A; van Baal WM; Berkhof J; Snijders PJ; Steenbergen RD
Int J Cancer; 2011 Nov; 129(9):2218-25. PubMed ID: 21190187
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
10. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
11. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy.
Dijkstra MG; van Niekerk D; Rijkaart DC; van Kemenade FJ; Heideman DA; Snijders PJ; Meijer CJ; Berkhof J
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):55-63. PubMed ID: 23733907
[TBL] [Abstract][Full Text] [Related]
12. Performance of DNA methylation analysis in the detection of high-grade cervical intraepithelial neoplasia or worse (CIN3+): a cross-sectional study.
Liu Y; Chen Y; Xiong J; Zhu P; An Y; Li S; Chen P; Li Q
Infect Agent Cancer; 2023 Nov; 18(1):77. PubMed ID: 38031140
[TBL] [Abstract][Full Text] [Related]
13. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
Luttmer R; De Strooper LM; Dijkstra MG; Berkhof J; Snijders PJ; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; van Baal WM; Graziosi PG; Quint WG; Spruijt JW; van Dijken DK; Heideman DA; Meijer CJ
Br J Cancer; 2016 Aug; 115(5):579-87. PubMed ID: 27415009
[TBL] [Abstract][Full Text] [Related]
14. ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection.
Zhu P; Xiong J; Yuan D; Li X; Luo L; Huang J; Wang B; Nie Q; Wang S; Dang L; Chen Y; Li S; An Y; Yang L; Liu R; He Y; Li X; Chen P; Zhou H; Li Q
Cell Rep Med; 2023 Aug; 4(8):101143. PubMed ID: 37557178
[TBL] [Abstract][Full Text] [Related]
15. PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women.
He L; Luo X; Bu Q; Jin J; Zhou S; He S; Zhang L; Lin Y; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2179916. PubMed ID: 36799003
[TBL] [Abstract][Full Text] [Related]
16. Selection of women at risk for cervical cancer in an HIV-infected South African population.
Van Zummeren M; Kremer WW; Van Aardt MC; Breytenbach E; Richter KL; Rozendaal L; Witte BI; De Strooper LMA; Hesselink AT; Heideman DAM; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
AIDS; 2017 Sep; 31(14):1945-1953. PubMed ID: 28692545
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions.
Cuzick J; Thomas Cox J; Zhang G; Einstein MH; Stoler M; Trupin S; Behrens CM
Int J Cancer; 2013 Feb; 132(4):959-66. PubMed ID: 22806936
[TBL] [Abstract][Full Text] [Related]
18. Cytological DNA methylation for cervical cancer screening: a validation set.
Kong L; Wang L; Wang Z; Xiao X; You Y; Wu H; Wu M; Liu P; Li L
Front Oncol; 2023; 13():1181982. PubMed ID: 37671063
[TBL] [Abstract][Full Text] [Related]
19. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.
Lai HC; Ou YC; Chen TC; Huang HJ; Cheng YM; Chen CH; Chu TY; Hsu ST; Liu CB; Hung YC; Wen KC; Yu MH; Wang KL
Cancer Med; 2014 Aug; 3(4):1062-74. PubMed ID: 24799352
[TBL] [Abstract][Full Text] [Related]
20. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.
Kotaniemi-Talonen L; Nieminen P; Anttila A; Hakama M
Br J Cancer; 2005 Oct; 93(8):862-7. PubMed ID: 16189520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
